PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries
Open Access
- 1 February 2016
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 24 (2) , 318-330
Abstract
No abstract availableKeywords
Funding Information
- Eli Lilly and Company
- National Institutes of Health (P50 AR054041, R01DE019902)
- California Institute for Regenerative Medicine (TR2-01780)
This publication has 53 references indexed in Scilit:
- Intermittent PTH administration and mechanical loading are anabolic for periprosthetic cancellous boneJournal of Orthopaedic Research, 2014
- Parathyroid Hormone 1-84 Accelerates Fracture-Healing in Pubic Bones of Elderly Osteoporotic WomenJournal of Bone and Joint Surgery, 2011
- Gene-Modified Adult Stem Cells Regenerate Vertebral Bone Defect in a Rat ModelMolecular Pharmaceutics, 2011
- Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4+ stem cells into the ischaemic heartCardiovascular Research, 2011
- Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34)Journal of Bone and Joint Surgery, 2005
- Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathwaysAmerican Journal of Physiology-Endocrinology and Metabolism, 2001
- Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2001
- A Quadripotential Mesenchymal Progenitor Cell Isolated from the Marrow of an Adult MouseJournal of Bone and Mineral Research, 1999
- Mortality after all major types of osteoporotic fracture in men and women: an observational studyThe Lancet, 1999
- Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapyJournal of Cellular Biochemistry, 1994